Tilray Brands, Inc. (TLRY)
Nasdaq · Healthcare · Drug Manufacturers - Specialty & Generic
$3.72+3.05%as of Oct 6, 2026, 4:35 AM ET
- Market cap
- $550M
- Forward P/E
- 20.9
- 52-week range
- $3.54 – $23.20
- 52-week change
- −77.15%
- EPS (trailing)
- −$1.13
- Analyst rating
- 2.2 Buy
- Next earnings
- Oct 8, 2026
Fiscal year to May 2026
- Revenue
- $915M (+11.46%)
- Net income
- −$121M
- Operating margin
- −6.9%
- Diluted EPS
- −$1.09
From the company’s annual report on SEC EDGAR.
About Tilray Brands, Inc.
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company,…
Headquarters: Leamington, Canada · 3,595 employees · tilray.com